Annual CFO
-$80.74 M
-$1.75 M-2.21%
December 31, 2024
Summary
- As of March 13, 2025, ALGS annual cash flow from operations is -$80.74 million, with the most recent change of -$1.75 million (-2.21%) on December 31, 2024.
- During the last 3 years, ALGS annual CFO has risen by +$34.92 million (+30.19%).
- ALGS annual CFO is now -72.65% below its all-time high of -$46.77 million, reached on December 31, 2019.
Performance
ALGS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$18.40 M
+$1.70 M+8.45%
December 31, 2024
Summary
- As of March 13, 2025, ALGS quarterly cash flow from operations is -$18.40 million, with the most recent change of +$1.70 million (+8.45%) on December 31, 2024.
- Over the past year, ALGS quarterly CFO has increased by +$1.70 million (+8.45%).
- ALGS quarterly CFO is now -35.16% below its all-time high of -$13.62 million, reached on June 30, 2023.
Performance
ALGS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$80.74 M
+$4.25 M+5.01%
December 31, 2024
Summary
- As of March 13, 2025, ALGS TTM cash flow from operations is -$80.74 million, with the most recent change of +$4.25 million (+5.01%) on December 31, 2024.
- Over the past year, ALGS TTM CFO has increased by +$4.25 million (+5.01%).
- ALGS TTM CFO is now -297.38% below its all-time high of -$20.32 million, reached on March 31, 2020.
Performance
ALGS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALGS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.2% | +8.4% | +5.0% |
| 3 y3 years | +30.2% | +17.8% | +0.7% |
| 5 y5 years | -72.7% | +17.8% | +0.7% |
ALGS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.2% | +30.2% | -35.2% | +50.9% | -15.5% | +30.2% |
| 5 y | 5-year | -72.7% | +30.2% | -35.2% | +50.9% | -297.4% | +30.2% |
| alltime | all time | -72.7% | +30.2% | -35.2% | +50.9% | -297.4% | +30.2% |
Aligos Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$80.74 M(+2.2%) | -$18.40 M(-8.4%) | -$80.74 M(-5.0%) |
| Sep 2024 | - | -$20.10 M(+3.1%) | -$85.00 M(-0.3%) |
| Jun 2024 | - | -$19.49 M(-14.3%) | -$85.23 M(+7.4%) |
| Mar 2024 | - | -$22.75 M(+0.4%) | -$79.36 M(+0.5%) |
| Dec 2023 | -$79.00 M(-0.5%) | -$22.66 M(+11.4%) | -$79.00 M(+8.0%) |
| Sep 2023 | - | -$20.34 M(+49.4%) | -$73.12 M(+4.6%) |
| Jun 2023 | - | -$13.62 M(-39.2%) | -$69.92 M(-14.0%) |
| Mar 2023 | - | -$22.39 M(+33.4%) | -$81.34 M(+2.5%) |
| Dec 2022 | -$79.39 M | -$16.78 M(-2.1%) | -$79.39 M(-20.7%) |
| Sep 2022 | - | -$17.14 M(-31.5%) | -$100.09 M(-7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$25.04 M(+22.5%) | -$108.32 M(+1.9%) |
| Mar 2022 | - | -$20.43 M(-45.5%) | -$106.30 M(-8.1%) |
| Dec 2021 | -$115.66 M(+55.7%) | -$37.48 M(+47.7%) | -$115.66 M(+18.2%) |
| Sep 2021 | - | -$25.37 M(+10.2%) | -$97.87 M(+9.9%) |
| Jun 2021 | - | -$23.02 M(-22.7%) | -$89.06 M(+6.4%) |
| Mar 2021 | - | -$29.80 M(+51.4%) | -$83.74 M(+12.8%) |
| Dec 2020 | -$74.26 M(+58.8%) | -$19.68 M(+18.8%) | -$74.26 M(+36.1%) |
| Sep 2020 | - | -$16.57 M(-6.4%) | -$54.58 M(+43.6%) |
| Jun 2020 | - | -$17.69 M(-12.9%) | -$38.01 M(+87.1%) |
| Mar 2020 | - | -$20.32 M | -$20.32 M |
| Dec 2019 | -$46.77 M | - | - |
FAQ
- What is Aligos Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Aligos Therapeutics?
- What is Aligos Therapeutics annual CFO year-on-year change?
- What is Aligos Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly CFO year-on-year change?
- What is Aligos Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Aligos Therapeutics?
- What is Aligos Therapeutics TTM CFO year-on-year change?
What is Aligos Therapeutics annual cash flow from operations?
The current annual CFO of ALGS is -$80.74 M
What is the all time high annual CFO for Aligos Therapeutics?
Aligos Therapeutics all-time high annual cash flow from operations is -$46.77 M
What is Aligos Therapeutics annual CFO year-on-year change?
Over the past year, ALGS annual cash flow from operations has changed by -$1.75 M (-2.21%)
What is Aligos Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ALGS is -$18.40 M
What is the all time high quarterly CFO for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly cash flow from operations is -$13.62 M
What is Aligos Therapeutics quarterly CFO year-on-year change?
Over the past year, ALGS quarterly cash flow from operations has changed by +$1.70 M (+8.45%)
What is Aligos Therapeutics TTM cash flow from operations?
The current TTM CFO of ALGS is -$80.74 M
What is the all time high TTM CFO for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM cash flow from operations is -$20.32 M
What is Aligos Therapeutics TTM CFO year-on-year change?
Over the past year, ALGS TTM cash flow from operations has changed by +$4.25 M (+5.01%)